CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 104 enrolled
Drug / intervention
Acrylic IOL +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02450799
NCT02450799N/ACompleted

Corrected VA With Long-Term Follow-Up After AcrySof® IOL Implantation

Alcon, a Novartis Company·interventional·Posted May 21, 2015·Updated Dec 9, 2016

In Brief

A clinical study evaluating Acrylic IOL, Silicone IOL, and 1 other intervention for Pseudophakia. Completed, enrolled 104 participants.

Detailed Summary

The purpose of this study is to compare the long-term visual acuity (VA) with an acrylic IOL to a silicone or polymethylmethacrylate (PMMA) IOL in cataract patients. This study will take place in Japan.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPseudophakia
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 21, 2015
Enrollment StartJun 1, 2015
Primary CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 11.1 years ago

Interventions

Acrylic IOLdevice

Acrylic IOL for long-term implantation in the cataract patient

Silicone IOLdevice

Silicone IOL for long-term implantation in the cataract patient

PMMA IOLdevice

Polymethylmethacrylate IOL for long-term implantation in the cataract patient